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Using Nucleic Acid-Gold Nanoparticle Conjugates in the Fight Against Bacteria that are Resistant to
Tetracycline
Antibiotics
Allen Livingston (2023)

Mentor: Dr. Timea Fernandez

Usage of RNA aptamers in
medicine

Abstract
Antibiotic resistance is major problem in modern medicine. Seventy percent of bacterial strains
are resistant to at least one antibiotic, making treatment of bacterial infections ever more
expensive and difficult. Currently, we are investigating the therapeutic potency of nucleic acidgold nanoparticle conjugates as treatments against bacteria that are resistant to the antibiotic
tetracycline. We hypothesize that by attaching RNA that binds to tetracycline to silver or gold
nanoparticles the resulting conjugates will work as a “Trojan-horse” tetracycline-delivery
vehicle that smuggles the antibiotic into the cell without being detected by cellular defense
systems. Moreover, we reason that silver or gold ions released by the nanoparticles add to the
antimicrobial effects of tetracycline.
To demonstrate the viability of this idea, we set out to generate a nuclease resistant variant
of the tetracycline binding RNA ykkCD and attach it to gold nanoparticles. During the summer
we furthered the progress of this research in there major ways. First, we optimized conditions
used for the polymerase chain reaction that generates the DNA template for RNA synthesis.
Second, we found the most efficient way to synthesize RNA containing modified nucleotides.
Usage of modified nucleotides is necessary to prevent degradation of the tetracycline-binding
RNA by cellular nucleases. Third, we optimized a stability assay to verify that the modified
RNAs are stable in cellular environments. Fourth, we attached the tetracycline binding RNA to
gold nanoparticles.
The next steps in the process would be to test the potency of this modified RNA-gold
nanoparticle conjugate against a tetracycline-resistant strain of the bacteria E. Coli.

We propose that using nucleic acid-gold nanoparticle
conjugates could be an effective way to treat
antibiotic-resistant bacterial infections. We
hypothesize that the tet-binding RNA aptamer will
deceive tet-resistant cells to uptake tetracycline by
acting as a caging compound. The tet-binding aptamer
is attached to gold nanoparticles, because bacteria is
known to uptake nanoparticles 4-40nm in size using
receptor mediated endocytosis. In addition to the
cytotoxic affect of tetracycline, the Ag+ ions released
form the nanoparticle will add to the antimicrobial
effect of tetracycline.

Antibiotic resistance is a problem in medicine. Seventy
percent of bacterial strains are resistant to at least one
antibiotic, making treatment of bacterial infections ever
more expensive and difficult.
Figure 3: Schematics showing how the tet-binding
RNA aptamer is attached to nanoparticles and expected
to exert is antibacterial function.

Why is the RNA modified?

Source: http://modmedmicro.nsms.ox.ac.uk/learn-more-aboutantibiotic-resistance/

RNA aptamers that are used as treatment have to be
resistant to cellular nucleases to exert their function.
Natural RNA nucleotides are replaced with 2’ modified
ones to avoid self-cleavage of RNA.

Figure 1: Mechanism of bacterial antibiotic resistance.

What are nanoparticles?
Nanoparticles are particles that vary in size from 1nm100nm, they are also tools that detect and deliver small
molecules. They are used in our work to transport medicine
to bacteria that would normally be resistant to the medicine.

To optimize in vitro DNA synthesis using PCR we varied
the concentration of the DNA template, Mg2+ and tested
whether the addition of DMSO increases DNA yield. We
found that elevated template DNA concertation increased
PCR yield but other additives did not.

Figure 5: Optimization on
template DNA synthesis with
PCR. From left to right with (1)
DNA ladder, (2) low template
mixture, (3) high template
mixture, (4) extra Mg²+, (5)
DMSO and (6) no enzyme
negative control. The samples
were resolved on a 1% agarose
gel that was ran at 100V for 30
minutes.

RNA synthesis was most efficient
2+
with 12ng/µl DNA, excess Mg
and nucleotides.

The tet-binding RNA aptamer is
resistant to cellular nucleases
To assess the stability of the tet-binding aptamer in
biological fluids we incubated the RNA with 10% bovine
serum for 80 minutes at 37°C. Start and end point samples
were compared on a denaturing PAGE. Modified RNA
samples only show slight degradation as indicated by a
single band that co-migrates with the start point samples.
Unmodified RNA (last sample) appears completely
degraded as it does not appear to be present in the end-point
sample.
Figure 7. RNA stability
assay. From left to right (1)
RNA molecular weight
ladder, (2) dUTP RNA
untreated, (3) dUTP RNA
treated, (4) 2’-F-dUTP RNA
untreated, (5) 2’-F-dUTP
RNA treated.

RNA was successfully attached to gold
nanoparticles
A slower migration of the RNA-AuNP conjugate compared to
AuNPs alone (gel retardation) indicates that the RNA was attached
to the nanoparticles

To optimize in vitro RNA synthesis we varied the
following parameters. The first optimization involved how
much the concentration of template DNA affected the
production of RNA. The second optimization varied the
amount of Mg2+ and NTP concentration and used modified
nucleotides. We found that 12ng/µl DNA, 20mM Mg2+ and
4mM NTP produced optimal RNA yield.

Figure 8. Attachment of RNA to gold
nanoparticles. From left to right. (1) gold
nanoparticles, (2) 2-F’-dUTP RNA-gold
nanoparticle conjugates and (3) dUTP
RNA-gold nanoparticle conjugates.
Samples were run on a 1% agarose gel for
60min at 100V.

Future goals
Figure 4: Left panel: RNA is prone to degradation
because the 2’OH act as nucleophile to attack the
adjacent phosphodiester bond and cleave the backbone
(red arrow). Right panel. Modified RNA nucleotides.
2’-fluoro modified nucleotides are used in this project.

Results
•
•
•

Figure 2: Schematic describing the versatile
applications of nanoparticles.

DNA synthesis was most efficient
with high template concentration

•

Optimized the synthesis of template DNA.
Optimized the conditions used to synthesize RNA.
Demonstrated that modified RNA is resistant to cellular
nucleases.
Attached gold nanoparticles to RNA.

Tet-aptamer RNA

•

•

Figure 6: Optimization of RNA synthesis. Left
panel: (1) DNA Ladder (2) no enzyme, (3) 1mM
NTP, 5mM Mg2+, (4) 1mM NTP, 20mM Mg2+, (5)
4mM NTP, 5mM Mg2+ and (6) 20 mM Mg2+, 4mM
NTP. Right panel: (1) DNA Ladder (2) No Enzyme
(3) 6ng/µl DNA (4) 12 ng/µl DNA (5) 15 ng/µl
DNA. Samples were resolved on a 10% denaturing
PAGE run for 30min with 15W.

We will make more of this Au-modified RNA nanoparticle
conjugate and test its efficacy on tet resistant E Coli.
We will try other tet-binding aptamers. We will use
secondary structure prediction and optimize the length of
the linker between the tet-binding aptamer and the sequence
that targets the RNA to the ribosome. We will aim for a
setup that maintain the structure both aptamers.
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